• 1. Asymmetric synthesis. Part III. Stereospecific synthesis of (R)-2-hydroxy-2-phenylpropionic acid, and (R)- and (S)-2-cyclohexyl-2-hydroxy-2-phenylacetic acid. Configurational relationship between (R)(–)-2-hydroxy-2-phenylpropionic acid and (S)(+)-2-phenylpropionic acid
  T. D. Inch,R. V. Ley,P. Rich J. Chem. Soc. C 1968 1693
• 2. Index of subjects, 1968
  J. Chem. Soc. C 1968 3115
• 3. Index of authors, 1968
  J. Chem. Soc. C 1968 3089
• 4. Total syntheses of spirocyclic PKS-NRPS-based fungal metabolites
  Deokhee Jo,Sunkyu Han Chem. Commun. 2018 54 6750
• 5. Asymmetric synthesis
  D. R. Boyd,M. A. Mckervey Q. Rev. Chem. Soc. 1968 22 95

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzene and substituted derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives

Introduction to (S)-(+)-2-Hydroxy-2-phenylpropionic Acid (CAS No. 3966-30-1)

(S)-(+)-2-Hydroxy-2-phenylpropionic Acid, identified by its Chemical Abstracts Service (CAS) number 3966-30-1, is a chiral compound that has garnered significant attention in the field of pharmaceutical chemistry and biomedicine. This compound, belonging to the class of β-hydroxy acids, exhibits a unique stereochemical configuration that imparts distinct biological activities, making it a valuable intermediate in the synthesis of various pharmacologically active molecules.

The< strong> molecular structure of (S)-(+)-2-Hydroxy-2-phenylpropionic Acid consists of a phenyl group attached to a propionic acid backbone with a hydroxyl substituent at the second carbon position. This arrangement contributes to its solubility in both polar and non-polar solvents, facilitating its use in diverse chemical and biological applications. The enantiomeric purity of this compound is crucial, as the (S)-configuration is often required for optimal biological efficacy.

In recent years, (S)-(+)-2-Hydroxy-2-phenylpropionic Acid has been extensively studied for its potential therapeutic applications. One of the most promising areas of research involves its role as a precursor in the synthesis of non-steroidal anti-inflammatory drugs (NSAIDs). The< strong> hydroxyl and carboxylic acid functional groups present in the molecule allow for facile modifications, enabling the development of novel derivatives with enhanced pharmacokinetic properties.

Moreover, studies have highlighted the< strong> antioxidant properties of (S)-(+)-2-Hydroxy-2-phenylpropionic Acid. Reactive oxygen species (ROS) are known to contribute to various pathological conditions, including inflammation and oxidative stress-related diseases. The compound's ability to scavenge ROS makes it a candidate for therapeutic intervention in conditions such as neurodegenerative disorders and cardiovascular diseases. Recent research has demonstrated its efficacy in reducing oxidative damage in cellular models, suggesting potential clinical applications.

The< strong> role of (S)-(+)-2-Hydroxy-2-phenylpropionic Acid in drug development has also been explored in the context of enzyme inhibition. Its structural features make it an attractive scaffold for designing inhibitors targeting key enzymes involved in metabolic pathways. For instance, derivatives of this compound have shown inhibitory activity against lipoxygenases and cyclooxygenases, which are critical enzymes in the biosynthesis of pro-inflammatory mediators. This has opened up new avenues for developing anti-inflammatory therapeutics with improved selectivity and reduced side effects.

Another area where (S)-(+)-2-Hydroxy-2-phenylpropionic Acid has shown promise is in the field of tissue engineering and regenerative medicine. The< strong> hydrophilic nature of the compound allows it to interact favorably with biological matrices, making it suitable for use in hydrogels and scaffolds designed for tissue repair. Research has indicated that formulations incorporating this compound can enhance cell adhesion and proliferation, promoting faster wound healing and tissue regeneration.

The synthesis of< strong> (S)-(+)-2-Hydroxy-2-phenylpropionic Acid is another area of active interest. Traditional synthetic routes often involve chiral resolution techniques, which can be costly and environmentally unfriendly. However, advancements in biocatalysis have enabled the use of enantioselective enzymes for the production of this compound. These enzymatic methods offer higher yields and lower environmental impact compared to traditional chemical synthesis, aligning with the growing demand for sustainable pharmaceutical manufacturing processes.

In conclusion, (S)-(+)-2-Hydroxy-2-phenylpropionic Acid (CAS No. 3966-30-1) is a versatile compound with significant potential in pharmaceutical and biomedical applications. Its unique stereochemistry, coupled with its functional groups, makes it a valuable intermediate for drug development. The< strong> antioxidant properties,< strong> enzyme inhibitory activity, and< strong> tissue engineering applications highlight its importance as a building block for innovative therapeutics. As research continues to uncover new uses for this compound, it is likely to play an increasingly pivotal role in addressing various health challenges.

• 13113-71-8((S)-(+)-2-hydroxy-2-phenylpropionic acid AldrichCPR)
• 2695-79-6(Benzeneacetic acid, a-hydroxy-4-methyl-a-(4-methylphenyl)-)
• 5928-68-7(Benzeneacetic acid, a-hydroxy-a-phenyl-, monopotassium salt(9CI))
• 30444-49-6(Propanoic acid,2-hydroxy-, monophenyl deriv. (9CI))
• 60057-62-7(rac a-Hydroxy Ibuprofen)
• 56031-84-6(Benzeneacetic acid, a-hydroxy-a,4-dimethyl-, (R)- (9CI))
• 83943-25-3(Benzeneacetic acid, α-hydroxy-α-phenyl-, calcium salt (2:1))
• 515-30-0(a-Phenyllactic acid)
• 5693-97-0(Benzeneacetic acid, a-hydroxy-a-(hydroxymethyl)-)
• 162050-73-9((S)-2-Hydroxy-2-(p-tolyl)propanoic acid)